JP Morgan Chase’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-547,883
| Closed | -$46.5M | – | 5980 |
|
|
2019
Q4 | $46.5M | Sell |
547,883
-116,817
| -18% | -$7.79M | 0.01% | 1008 |
|
|
2019
Q3 | $33.2M | Sell |
664,700
-37,110
| -5% | -$1.48M | 0.01% | 1206 |
|
|
2019
Q2 | $25M | Buy |
701,810
+16,112
| +2% | +$526K | ﹤0.01% | 1406 |
|
|
2019
Q1 | $19.2M | Buy |
685,698
+144,810
| +27% | +$3.41M | ﹤0.01% | 1570 |
|
|
2018
Q4 | $10.4M | Sell |
540,888
-85,874
| -14% | -$2M | ﹤0.01% | 1984 |
|
|
2018
Q3 | $18.7M | Sell |
626,762
-334,454
| -35% | -$12.6M | ﹤0.01% | 1711 |
|
|
2018
Q2 | $35.3M | Buy |
961,216
+372,407
| +63% | +$12.1M | 0.01% | 1181 |
|
|
2018
Q1 | $19.4M | Sell |
588,809
-640,689
| -52% | -$20M | ﹤0.01% | 1534 |
|
|
2017
Q4 | $33.6M | Buy |
1,229,498
+972,264
| +378% | +$29.9M | 0.01% | 1199 |
|
|
2017
Q3 | $9.42M | Sell |
257,234
-8,859
| -3% | -$327K | ﹤0.01% | 2037 |
|
|
2017
Q2 | $10.1M | Sell |
266,093
-347,680
| -57% | -$15.5M | ﹤0.01% | 1960 |
|
|
2017
Q1 | $30M | Sell |
613,773
-353,400
| -37% | -$16.1M | 0.01% | 1206 |
|
|
2016
Q4 | $32.8M | Buy |
967,173
+314,917
| +48% | +$11.2M | 0.01% | 1149 |
|
|
2016
Q3 | $24.6M | Sell |
652,256
-332,192
| -34% | -$12.5M | 0.01% | 1240 |
|
|
2016
Q2 | $33.1M | Sell |
984,448
-54,274
| -5% | -$1.91M | 0.01% | 1048 |
|
|
2016
Q1 | $33M | Buy |
1,038,722
+417,496
| +67% | +$13.6M | 0.01% | 1028 |
|
|
2015
Q4 | $23.2M | Sell |
621,226
-29,998
| -5% | -$1.13M | 0.01% | 1228 |
|
|
2015
Q3 | $24.7M | Sell |
651,224
-113,884
| -15% | -$4M | 0.01% | 1135 |
|
|
2015
Q2 | $21.9M | Sell |
765,108
-138
| -0% | -$3.84K | 0.01% | 1344 |
|
|
2015
Q1 | $21.4M | Buy |
765,246
+91,013
| +13% | +$2.56M | ﹤0.01% | 1392 |
|
|
2014
Q4 | $18.7M | Sell |
674,233
-205,421
| -23% | -$5.09M | ﹤0.01% | 1527 |
|
|
2014
Q3 | $19.6M | Sell |
879,654
-30,244
| -3% | -$768K | ﹤0.01% | 1458 |
|
|
2014
Q2 | $26.4M | Buy |
909,898
+207,174
| +29% | +$5.53M | 0.01% | 1171 |
|
|
2014
Q1 | $20M | Sell |
702,724
-73,857
| -10% | -$2.44M | 0.01% | 1320 |
|
|
2013
Q4 | $30M | Sell |
776,581
-206,754
| -21% | -$7.39M | 0.01% | 1074 |
|
|
2013
Q3 | $33M | Sell |
983,335
-153,144
| -13% | -$4.88M | 0.01% | 1023 |
|
|
2013
Q2 | $35M | Buy |
+1,136,479
| New | +$38M | 0.01% | 922 |
|
Other funds holding MDCO
JP Morgan Chase's MDCO Position: Q1 2020 in Review
JP Morgan Chase sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 547,883 shares — an estimated $46.5M sold.
JP Morgan Chase first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $46.5M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- JP Morgan Chase reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- JP Morgan Chase sold 547,883 Medicines Co shares in Q1 2020, an estimated $46.5M.
- JP Morgan Chase first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- JP Morgan Chase's Medicines Co position peaked at $46.5M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.